Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis.
<h4>Background</h4>Xpert MTB/RIF (Xpert) is a promising new rapid diagnostic technology for tuberculosis (TB) that has characteristics that suggest large-scale roll-out. However, because the test is expensive, there are concerns among TB program managers and policy makers regarding its affordability...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Public Library of Science (PLoS)
2011-11-01
|
| coleção: | PLoS Medicine |
| Acesso em linha: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22087078/pdf/?tool=EBI |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
